Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Cerebral small vessel disease-related brain lesions such as white matter lesions and lacunes are common findings of magnetic resonance imaging in the elderly. These lesions are thought to be major contributors to disability in old age, and risk factors that include age and hypertension have been established. The radiological, histopathologic and clinical phenotypes of age-related cerebral small vessel disease remarkably resemble autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy, which is caused by mutations in NOTCH3. We hypothesized that genetic variations in NOTCH3 also play a role in age-related cerebral small vessel disease. We directly sequenced all 33 exons, the promoter and 3'-untranslated region of NOTCH3 in 195 participants with either coalescent white matter lesions or lacunes and compared the results to 82 randomly selected participants with no focal changes on magnetic resonance images in the Austrian Stroke Prevention Study. We detected nine common and 33 rare single nucleotide polymorphisms, of which 20 were novel. All common single nucleotide polymorphisms were genotyped in the entire cohort (n = 888), and four of them, rs1043994, rs10404382, rs10423702 and rs1043997, were associated significantly with both the presence and progression of white matter lesions. The association was confined to hypertensives, a result which we replicated in the Cohorts for Heart and Ageing Research in Genomic Epidemiology Consortium on an independent sample of 4773 stroke-free hypertensive elderly individuals of European descent (P = 0.04). The 33 rare single nucleotide polymorphisms were scattered over the NOTCH3 gene with three being located in the promoter region, 24 in exons (18 non-synonymous), three in introns and three in the 3'-untranslated region. None of the single nucleotide polymorphisms affected a cysteine residue. Sorting Intolerant From Tolerant, PolyPhen2 analyses and protein structure simulation consistently predicted six of the non-synonymous single nucleotide polymorphisms (H170R, P496L, V1183M, L1518M, D1823N and V1952M) to be functional, with four being exclusively or mainly detected in subjects with severe white matter lesions. In four individuals with rare non-synonymous single nucleotide polymorphisms, we noted anterior temporal lobe hyperintensity, hyperintensity in the external capsule, lacunar infarcts or subcortical lacunar lesions. None of the observed abnormalities were specific to cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy. This is the first comprehensive study investigating (i) the frequency of NOTCH3 variations in community-dwelling elderly and (ii) their effect on cerebral small vessel disease related magnetic resonance imaging phenotypes. We show that the NOTCH3 gene is highly variable with both common and rare single nucleotide polymorphisms spreading across the gene, and that common variants at the NOTCH3 gene increase the risk of age-related white matter lesions in hypertensives. Additional investigations are required to explore the biological mechanisms underlying the observed association.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite the identification of MRI differences between CADASIL patients and non-carriers, these differences are overall limited and not consistently found across studies.”
From Clinical and research applications of magnetic resonance imaging in the study of CADASIL (2019) · cites this paper as [63]
In the citing paper
“MRI features described as specific to CADASIL, including temporal pole WMH, have been observed in a considerable proportion of subjects without NOTCH3 mutations, limiting their specificity [51, 58, 63].”
From Clinical and research applications of magnetic resonance imaging in the study of CADASIL (2019) · cites this paper as [63]
In the citing paper
“In terms of other common vascular risk factors, concurrent smoking also appears to be a key risk factor for WMH and their progression,97 whereas statins did not prevent WMH progression.12”
From Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging (2013) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J. M., & Wouters, E. J. M. (2016) · Gerontology · doi:10.1159/000430949 · Cited by 19,690
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. (2015) · Gerontology · doi:10.1159/000362720 · Cited by 18,909
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Protein structure prediction on the Web: a case study using the Phyre server
Kelley, L. A., & Sternberg, M. J. E. (2009) · Nature Protocols · doi:10.1038/nprot.2009.2 · Cited by 4,175
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313 · cited 3×
“BRAIN A JOURNAL OF NEUROLOGY Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease Helena Schmidt,1,2 Marion Zeginigg,1 Marco Wiltgen,3 Paul Freudenberger,1 Katja Petrovic,2 Margherita Cavalieri,2 Pierre Gider,1 Christian Enzinger,2,4…”
BackgroundNotch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
Joutel, A., Corpechot, C., Ducros, A., Vahedi, K., Chabriat, H., Mouton, P., Alamowitch, S., Domenga, V., Cécillion, M., Maréchal, E., et al. (1996) · Nature · doi:10.1038/383707a0 · Cited by 2,068
(2014) · International Journal of Stroke · doi:10.1111/ijs.12374_18 · Cited by 1,166
O'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., Bowler, J. V., Ballard, C., DeCarli, C., Gorelick, P. B., et al. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00305-3 · Cited by 1,139
Chabriat, H., Joutel, A., Dichgans, M., Tournier-Lasserve, E., & Bousser, M.-G. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70127-9 · Cited by 1,088
Breteler, M. M. B., van Swieten, J. C., Bots, M. L., Grobbee, D. E., Claus, J. J., van den Hout, J. H. W., van Harskamp, F., Tanghe, H. L. J., de Jong, P. T. V. M., van Gijn, J., et al. (1994) · Neurology · doi:10.1212/wnl.44.7.1246 · Cited by 1,006
The phenotypic spectrum of CADASIL: Clinical findings in 102 cases
Dichgans, M., Mayer, M., Uttner, I., Brüning, R., Müller‐Höcker, J., Rungger, G., Ebke, M., Klockgether, T., & Gasser, T. (1998) · Annals of Neurology · doi:10.1002/ana.410440506 · Cited by 735
Clinical spectrum of CADASIL: a study of 7 families
Chabriat, H., Vahedi, K., Bousser, M. G., Iba-Zizen, M. T., Joutel, A., Nibbio, A., Nagy, T. G., Tournier Lasserve, E., Krebs, M. O., Julien, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91557-5 · Cited by 669 · cited 1×
“…arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL), a monogenic form of systemic non-amyloid arteriopathy primarily affecting the brain (Adib-Samii et al., 2010; Chabriat et al., 1995, 2009; Joutel et al., 1996; Dichgans et al., 1998; Desmond et al., 1999; Reyes et al., 2009).”
BackgroundCerebral White Matter Is Highly Vulnerable to Ischemia
Pantoni, L., Garcia, J. H., & Gutierrez, J. A. (1996) · Stroke · doi:10.1161/01.str.27.9.1641 · Cited by 608
Psaty, B. M., O'Donnell, C. J., Gudnason, V., Lunetta, K. L., Folsom, A. R., Rotter, J. I., Uitterlinden, A. G., Harris, T. B., Witteman, J. C. M., & Boerwinkle, E. (2009) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.829747 · Cited by 599
Self-citationNotch3 is required for arterial identity and maturation of vascular smooth muscle cells
Domenga, V., Fardoux, P., Lacombe, P., Monet, M., Maciazek, J., Krebs, L. T., Klonjkowski, B., Berrou, E., Mericskay, M., Li, Z., et al. (2004) · Genes & Development · doi:10.1101/gad.308904 · Cited by 536
Longstreth, W. T., Arnold, A. M., Beauchamp, N. J., Manolio, T. A., Lefkowitz, D., Jungreis, C., Hirsch, C. H., O’Leary, D. H., & Furberg, C. D. (2005) · Stroke · doi:10.1161/01.str.0000149625.99732.69 · Cited by 474
Inzitari, D., Pracucci, G., Poggesi, A., Carlucci, G., Barkhof, F., Chabriat, H., Erkinjuntti, T., Fazekas, F., Ferro, J. M., Hennerici, M., et al. (2009) · BMJ · doi:10.1136/bmj.b2477 · Cited by 415 · cited 1×
“They are also predictors of future disability (Inzitari et al., 2009).”
BackgroundSelf-citationSchmidt, R., Ropele, S., Enzinger, C., Petrovic, K., Smith, S., Schmidt, H., Matthews, P. M., & Fazekas, F. (2005) · Annals of Neurology · doi:10.1002/ana.20630 · Cited by 408
Self-citationJoutel, A., Monet-Leprêtre, M., Gosele, C., Baron-Menguy, C., Hammes, A., Schmidt, S., Lemaire-Carrette, B., Domenga, V., Schedl, A., Lacombe, P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39733 · Cited by 379
MRI white matter hyperintensities: Three-year follow-up of the Austrian Stroke Prevention Study
Schmidt, R., Fazekas, F., Kapeller, P., Schmidt, H., & Hartung, H.-P. (1999) · Neurology · doi:10.1212/wnl.53.1.132 · Cited by 342
Self-citationDiagnostic strategies in CADASIL
Markus, H. S., Martin, R. J., Simpson, M. A., Dong, Y. B., Ali, N., Crosby, A. H., & Powell, J. F. (2002) · Neurology · doi:10.1212/wnl.59.8.1134 · Cited by 335
Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins
Carmelli, D., DeCarli, C., Swan, G. E., Jack, L. M., Reed, T., Wolf, P. A., & Miller, B. L. (1998) · Stroke · doi:10.1161/01.str.29.6.1177 · Cited by 321
The Natural History of CADASIL: A Pooled Analysis of Previously Published Cases
Desmond, D. W., Moroney, J. T., Lynch, T., Chan, S., Chin, S. S., & Mohr, J. P. (1999) · Stroke · doi:10.1161/01.str.30.6.1230 · Cited by 269
Genetic variation in white matter hyperintensity volume in the Framingham Study
Atwood, L. D., Wolf, P. A., Heard-Costa, N. L., Massaro, J. M., Beiser, A., D’Agostino, R. B., & DeCarli, C. (2004) · Stroke · doi:10.1161/01.str.0000129643.77045.10 · Cited by 240 · cited 3×
“BRAIN A JOURNAL OF NEUROLOGY Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease Helena Schmidt,1,2 Marion Zeginigg,1 Marco Wiltgen,3 Paul Freudenberger,1 Katja Petrovic,2 Margherita Cavalieri,2 Pierre Gider,1 Christian Enzinger,2,4…”
BackgroundAdib-Samii, P., Brice, G., Martin, R. J., & Markus, H. S. (2010) · Stroke · doi:10.1161/strokeaha.109.568402 · Cited by 239 · cited 1×
“…arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL), a monogenic form of systemic non-amyloid arteriopathy primarily affecting the brain (Adib-Samii et al., 2010; Chabriat et al., 1995, 2009; Joutel et al., 1996; Dichgans et al., 1998; Desmond et al., 1999; Reyes et al., 2009).”
BackgroundSrikanth, V., Beare, R., Blizzard, L., Phan, T., Stapleton, J., Chen, J., Callisaya, M., Martin, K., & Reutens, D. (2009) · Stroke · doi:10.1161/strokeaha.108.524355 · Cited by 233
van den Boom, R., Lesnik Oberstein, S. A. J., Ferrari, M. D., Haan, J., & van Buchem, M. A. (2003) · Radiology · doi:10.1148/radiol.2293021354 · Cited by 224
Genome‐wide association studies of cerebral white matter lesion burden: The CHARGE consortium
Fornage, M., Debette, S., Bis, J. C., Schmidt, H., Ikram, M. A., Dufouil, C., Sigurdsson, S., Lumley, T., DeStefano, A. L., Fazekas, F., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22403 · Cited by 214
Self-citationRosano, C., Brach, J., Longstreth Jr., W. T., & Newman, A. B. (2006) · Neuroepidemiology · doi:10.1159/000089240 · Cited by 198
Progression of Leukoaraiosis and Cognition
Schmidt, R., Petrovic, K., Ropele, S., Enzinger, C., & Fazekas, F. (2007) · Stroke · doi:10.1161/strokeaha.107.489112 · Cited by 169
Self-citationAn overview of Notch3 function in vascular smooth muscle cells
Wang, T., Baron, M., & Trump, D. (2007) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2007.07.006 · Cited by 160
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
Dichgans, M. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00270-8 · Cited by 159
Cyclic Strain Inhibits Notch Receptor Signaling in Vascular Smooth Muscle Cells In Vitro
Morrow, D. J., Sweeney, C., Birney, Y. A., Cummins, P. M., Walls, D., Redmond, E. M., & Cahill, P. A. (2005) · Circulation Research · doi:10.1161/01.res.0000159182.98874.43 · Cited by 156
Notch and Vascular Smooth Muscle Cell Phenotype
Morrow, D., Guha, S., Sweeney, C., Birney, Y., Walshe, T., O’Brien, C., Walls, D., Redmond, E. M., & Cahill, P. A. (2008) · Circulation Research · doi:10.1161/circresaha.108.187534 · Cited by 151
Apathy: A major symptom in CADASIL
Reyes, S., Viswanathan, A., Godin, O., Dufouil, C., Benisty, S., Hernandez, K., Kurtz, A., Jouvent, E., O’Sullivan, M., Czernecki, V., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000344166.03470.f8 · Cited by 147
Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease
Arboleda-Velasquez, J. F., Manent, J., Lee, J. H., Tikka, S., Ospina, C., Vanderburg, C. R., Frosch, M. P., Rodríguez-Falcón, M., Villen, J., Gygi, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101964108 · Cited by 138
Linking Notch signaling to ischemic stroke
Arboleda-Velasquez, J. F., Zhou, Z., Shin, H. K., Louvi, A., Kim, H.-H., Savitz, S. I., Liao, J. K., Salomone, S., Ayata, C., Moskowitz, M. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709867105 · Cited by 102
Characteristics of CADASIL in Korea: A novel cysteine-sparing Notch3 mutation
Kim, Y., Choi, E. J., Choi, C. G., Kim, G., Choi, J. H., Yoo, H. W., & Kim, J. S. (2006) · Neurology · doi:10.1212/01.wnl.0000216259.99811.50 · Cited by 98
Launer, L. J., Berger, K., Breteler, M. M. B., Dufouil, C., Fuhrer, R., Giampaoli, S., Nilsson, L.-G., Pajak, A., de Ridder, M., van Dijk, E. J., et al. (2006) · Neuroepidemiology · doi:10.1159/000089233 · Cited by 87
Self-citationSchmidt, R., Lechner, H., Fazekas, F., Niederkorn, K., Reinhart, B., Grieshofer, P., Horner, S., Offenbacher, H., Koch, M., Eber, B., et al. (1994) · Neuroepidemiology · doi:10.1159/000110396 · Cited by 84
Self-citationCADASIL: Experimental Insights From Animal Models
Ayata, C. (2010) · Stroke · doi:10.1161/strokeaha.110.595207 · Cited by 75
Blood pressure variability and silent cerebral damage in essential hypertension
Gómez-Angelats, E., DELASIERRA, A., Sierra, C., Parati, G., Mancia, G., & Coca, A. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.05.002 · Cited by 69
Schmidt, H., Fazekas, F., Kostner, G. M., van Duijn, C. M., & Schmidt, R. (2001) · Stroke · doi:10.1161/01.str.32.2.405 · Cited by 59
Self-citationActivating NOTCH3 mutation in a patient with small-vessel-disease of the Brain
Fouillade, C., Chabriat, H., Riant, F., Mine, M., Arnoud, M., Magy, L., Bousser, M. G., Tournier-Lasserve, E., & Joutel, A. (2008) · Human Mutation · doi:10.1002/humu.9527 · Cited by 59
Distribution pattern of Notch3 mutations suggests a gain-of-function mechanism for CADASIL
Donahue, C. P., & Kosik, K. S. (2003) · Genomics · doi:10.1016/s0888-7543(03)00206-4 · Cited by 56
Two Japanese CADASIL families exhibiting Notch3 mutation R75P not involving cysteine residue
Mizuno, T., Muranishi, M., Torugun, T., Tango, H., Nagakane, Y., Kudeken, T., Kawase, Y., Kawabe, K., Oshima, F., Yaoi, T., et al. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.1391 · Cited by 49
Sussman, J. L., Abola, E. E., Lin, D., Jiang, J., Manning, N. O., & Prilusky, J. (1999) · Genetica · doi:10.1023/a:1003753517358 · Cited by 47
Usher syndrome type 1 due to missense mutations on bothCDH23 alleles: investigation of mRNA splicing
Bećirović, E., Ebermann, I., Nagy, D., Zrenner, E., Seeliger, M. W., & Bolz, H. J. (2008) · Human Mutation · doi:10.1002/humu.9526 · Cited by 42
Schmidt, H., Aulchenko, Y. S., Schweighofer, N., Schmidt, R., Frank, S., Kostner, G. M., Ott, E. O., & van Duijn, C. M. (2004) · Stroke · doi:10.1161/01.str.0000144646.96121.d2 · Cited by 28
Self-citationLi, Z., Yu, H. B., Zhuang, W., & Mukamel, S. (2007) · Chemical Physics Letters · doi:10.1016/j.cplett.2007.12.022 · Cited by 21
The Genetic Code—More Than Just a Table
Berleant, D., White, M., Pierce, E. A., Tudoreanu, E., Boeszoermenyi, A., Shtridelman, Y., & Macosko, J. C. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9060-9 · Cited by 19
Bridging the gap between the sequence and 3D structure world
Prilusky, J. (1999) · Cited by 5
Research works printed but not linked: 1
- 1998, Annals of neurology, 44, 31
Cited by
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Stroke injury, cognitive impairment and vascular dementia
Kalaria, R. N., Akinyemi, R., & Ihara, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.015 · Cited by 647
Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL
Rutten, J. W., Dauwerse, H. G., Gravesteijn, G., van Belzen, M. J., van der Grond, J., Polke, J. M., Bernal‐Quiros, M., & Lesnik Oberstein, S. A. J. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.344 · Cited by 200
Abraham, H. M. A., Wolfson, L., Moscufo, N., Guttmann, C. R. G., Kaplan, R. F., & White, W. B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.121 · Cited by 146
Is Hypertension Associated With an Accelerated Aging of the Brain?
Tzourio, C., Laurent, S., & Debette, S. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.00147 · Cited by 150
Self-citation
Metadata
- Authors
- Schmidt, H., Zeginigg, M., Wiltgen, M., Freudenberger, P., Petrovic, K., Cavalieri, M., Gider, P., Enzinger, C., Fornage, M., Debette, S., Rotter, J. I., Ikram, M. A., Launer, L. J., Schmidt, R., & on behalf of the CHARGE consortium Neurology working group
- Affiliations
- Medical University of Graz (AT)
- Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (US)
- Boston University (US)
- Cedars-Sinai Medical Center (US)
- Erasmus MC (NL)
- National Institutes of Health (US)
- Corresponding author
- Schmidt, H.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-10-17
- Volume
- 134
- Issue
- 11
- Pages
- 3384-3397
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC3212720
- OpenAlex
- W2076428954
- Cited by
- 112
- References
- 60
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 4 · 2022: 9 · 2021: 12 · 2020: 8 · 2019: 7 · 2018: 8 · 2017: 6 · 2016: 4 · 2015: 17 · 2014: 11 · 2013: 7 · 2012: 5
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Funders
- School of Medicine, Boston University
- Cedars-Sinai Medical Center
- European Commission
- ZonMw (050-060-810)
- Austrian Science Fund (P20545)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (050.060.810, 175.010.2005.011)
- Karl-Franzens-Universität Graz
- Medizinische Universität Graz
- Hjartavernd (N01-AG-1-2100)
- National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc045133-001, n01ag12100-57-0-2, n01hc085079-024, n01hc015103-009, n01hc085084-005, n01hc55021-47-0-1, n01hc085085-011, n01hc085083-027, n01hc55020-39-0-0, n01hc085080-026, n01hc55016-37-0-0, n01hc055022-024, n01hc085086-022, n01hc55019-35-0-1, n01hc55018-38-0-1, n01hc25195-41-0-1, n01hc55222-0-0-0, HHSN268200625226C, n01hc075150-004, n01hc035129-010, n01hc55015-48-0-1)
- U.S. Public Health Service (HHSN 268200625226C)
- National Institute on Aging (N01-HC-55021, AG-16495, N01HC85079, N01 HC‐15103, N01-AG12100, N01-AG012100, N02-HL-6-4278, N01HC55222, N01‐HC‐35129, R01AG031287, N01-HC-75150, AG031287, AG08122, N01-HC-55018, AG033193, R01AG016495, HL080295, N01‐HC‐45133, N01-HC-55015, N01‐HC‐85086, N01-HC-55019, N01-HC-55020, N01-HC-55016, R01AG033193, R01AG008122, N01-HC-55022)
- National Heart, Lung, and Blood Institute (N01-HC-85081, DK-063491, N01HC85085, N01-HC55022, N01 HC085086, HC-55016, N01HC-85083, N01 HC055016, N01-HC-55018, HC-85086, HC25195, N01HC15103, N01 HC 55020, N01 HC085079, HC85079, N01‐HC25195, HC-55021, HL-087652, HC-55018, N01 HC 55019, N01HC85082, N01HC‐75150, AG08122, N01 HC85086, R01HL087652, HC-55022, N01 HC055020, N01HC85080, AG031287, HC-55019, N01-HC, HC-35129, N02- HL-64278, N01 HC055018, N01 HC55222, HL-093029, HC-55015, HC-45133, HHSN268200625226C, N01‐HC‐45133, HC-55020, N01-HC-025195, N01-HC55016, R01HL087641, N01 HC055022, R01HL093029, U01HL080295, N01 HC055019, AG16495, HL087641, AG033193, HL080295, N01‐HC‐55015, N01-HC55021, N01 HC075150, N01 HC055021, HC-15103, N01 HC055015, N01-HC85079, N01-HC85084, N01HC35129)
- National Human Genome Research Institute (U01HG004402)
- National Eye Institute
- National Institute on Deafness and Other Communication Disorders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, N01-HC-55016, N01-HC-55018, N01-HC-55021, N01-HC-55020, N01-HC-55015, N01-HC-55019, N01-HC-55022, P30DK063491)
- National Institute of Neurological Disorders and Stroke (NS17950, R01NS017950)
- National Center for Research Resources (UL1RR025005, M01RR000425, M01-RR00425)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- NOTCH3 gene, cerebral small vessel disease, white matter lesions, lacunes, single nucleotide polymorphisms, rare variants, hypertension, genetic susceptibility, novel variants, variant effect prediction, older adults, stroke prevention, CHARGE consortium
- MeSH terms
- Receptor, Notch3, Aged, Aged, 80 and over, Alleles, Brain, Exons, Female, Follow-Up Studies, Genotype, Humans, Hypertension, Magnetic Resonance Imaging, Male, Middle Aged, Phenotype, Promoter Regions, Genetic, Prospective Studies, Receptors, Notch, Genetic Association Studies, Cerebral Small Vessel Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.